JPWO2020203609A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020203609A5
JPWO2020203609A5 JP2021511897A JP2021511897A JPWO2020203609A5 JP WO2020203609 A5 JPWO2020203609 A5 JP WO2020203609A5 JP 2021511897 A JP2021511897 A JP 2021511897A JP 2021511897 A JP2021511897 A JP 2021511897A JP WO2020203609 A5 JPWO2020203609 A5 JP WO2020203609A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
pyrrolidin
pyridin
acetamide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021511897A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020203609A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/013542 external-priority patent/WO2020203609A1/ja
Publication of JPWO2020203609A1 publication Critical patent/JPWO2020203609A1/ja
Publication of JPWO2020203609A5 publication Critical patent/JPWO2020203609A5/ja
Ceased legal-status Critical Current

Links

JP2021511897A 2019-03-29 2020-03-26 Ceased JPWO2020203609A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019068811 2019-03-29
PCT/JP2020/013542 WO2020203609A1 (ja) 2019-03-29 2020-03-26 掻痒を治療するためのt型カルシウムチャネル阻害剤の使用

Publications (2)

Publication Number Publication Date
JPWO2020203609A1 JPWO2020203609A1 (https=) 2020-10-08
JPWO2020203609A5 true JPWO2020203609A5 (https=) 2023-03-22

Family

ID=72667788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021511897A Ceased JPWO2020203609A1 (https=) 2019-03-29 2020-03-26

Country Status (6)

Country Link
US (1) US20220226299A1 (https=)
EP (1) EP3950059A4 (https=)
JP (1) JPWO2020203609A1 (https=)
AU (1) AU2020250468A1 (https=)
CA (1) CA3135344A1 (https=)
WO (1) WO2020203609A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220363667A1 (en) * 2018-07-17 2022-11-17 Nippon Chemiphar Co., Ltd. T-type calcium channel blocker
US20250129021A1 (en) * 2023-09-19 2025-04-24 Interdict Bio, Inc. Small molecule protein synthesis modulators

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831447A1 (de) * 1978-07-18 1980-01-31 Hoechst Ag 2-(4-aminopiperidino)-3,4-dihydrochinoline und verfahren zu ihrer herstellung
DE69732868T2 (de) * 1996-11-25 2006-04-13 Toray Industries, Inc. Mittel gegen Juckreiz
JP2002088073A (ja) * 2000-09-08 2002-03-27 Yamanouchi Pharmaceut Co Ltd 抗アンドロゲン剤
JP4775259B2 (ja) * 2004-03-31 2011-09-21 味の素株式会社 アニリン誘導体
AU2005273986A1 (en) * 2004-08-10 2006-02-23 Incyte Corporation Amido compounds and their use as pharmaceuticals
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators
US8030501B2 (en) 2006-07-28 2011-10-04 Kaneka Corporation Process for producing optically active 3-amino nitrogen-containing compounds
DE102007018151A1 (de) 2007-04-16 2008-10-23 Günenthal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
WO2009131196A1 (ja) * 2008-04-24 2009-10-29 武田薬品工業株式会社 置換ピロリジン誘導体およびその用途
MX2011005954A (es) 2008-12-05 2011-10-11 Astellas Pharma Inc Compuesto de 2h-cromeno y su derivado.
JP2013028537A (ja) * 2009-11-11 2013-02-07 Dainippon Sumitomo Pharma Co Ltd N−ベンジルアミド誘導体およびそれを含有する医薬組成物
ES2617339T3 (es) * 2010-12-16 2017-06-16 Calchan Limited Derivados de pirrolopirimidina inhibidores de ASK1
BR112013021675A2 (pt) 2011-02-25 2016-11-01 Array Biopharma Inc compostos de triazolopiridina como inibidores de pim cinase
AR085435A1 (es) 2011-03-17 2013-10-02 Bristol Myers Squibb Co Inhibidores de pirrolopiridazina jak3 y su uso para el tratamiento de enfermedades inflamatorias y autoinmunes
WO2013026914A1 (en) 2011-08-25 2013-02-28 F. Hoffmann-La Roche Ag Serine/threonine pak1 inhibitors
EP2790705B1 (en) 2011-12-15 2017-12-06 Novartis AG Use of inhibitors of the activity or function of pi3k
CN104603098B (zh) 2012-03-30 2016-06-29 桑多斯股份公司 2-(3,4-二氟苯基)环丙胺衍生物和盐的合成
WO2014010748A1 (en) 2012-07-10 2014-01-16 Shionogi & Co., Ltd. Cyclopropane derivative having bace1 inhibiting activity
EP3391898A3 (en) 2013-03-13 2019-02-13 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
DK3027615T3 (da) * 2013-08-02 2021-10-25 Pasteur Institut Korea Antiinfektionsforbindelser
ES2670550T3 (es) * 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Derivados de quinolina selectivamente sustituidos
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
NO2721710T3 (https=) 2014-08-21 2018-03-31
WO2016095204A1 (en) 2014-12-19 2016-06-23 Merck Sharp & Dohme Corp. Pyrrolidine orexin receptor antagonists
CN105837577B (zh) * 2015-02-02 2019-01-25 四川大学 1-(嘧啶-4-基)3-胺基哌啶衍生物及其制备方法和用途
PT3889145T (pt) * 2015-12-17 2024-04-02 Merck Patent Gmbh 8-ciano-5-piperidino-quinolinas como antagonistas de tlr7/8 e suas utilizações para tratamento de distúrbios imunitários
EP3404021A4 (en) 2016-01-12 2019-09-11 Nippon Chemiphar Co., Ltd. VOLTAGE-RELATED T-TYPE CALCIUM CHANNEL INHIBITOR
US10973913B2 (en) * 2016-02-16 2021-04-13 Washington University JAK inhibitors and uses thereof
CN105906545B (zh) 2016-05-06 2018-06-29 广州康瑞泰药业有限公司 一种合成西他沙星中间体(7s)-5-氮杂螺[2.4]庚烷-7-基氨基甲酸叔丁酯的制备方法
SG11201811023UA (en) * 2016-06-23 2019-01-30 St Jude Childrens Res Hospital Small molecule modulators of pantothenate kinases
CN107556318B (zh) * 2017-08-22 2020-08-11 山东大学 一种含哌啶的吡咯并嘧啶类化合物及其制备方法与应用
JP7527967B2 (ja) * 2017-12-27 2024-08-05 セント ジュード チルドレンズ リサーチ ホスピタル,インコーポレイティド Castorに関連する障害を治療する方法
WO2019133635A1 (en) * 2017-12-27 2019-07-04 St. Jude Children's Research Hospital Small molecule modulators of pantothenate kinases
US20220363667A1 (en) * 2018-07-17 2022-11-17 Nippon Chemiphar Co., Ltd. T-type calcium channel blocker
CA3108099A1 (en) * 2018-07-31 2020-02-06 Merck Patent Gmbh Tlr7/8 antagonists and uses thereof

Similar Documents

Publication Publication Date Title
JP2025016684A5 (https=)
KR102493967B1 (ko) 신규한 화합물
RU2462464C2 (ru) Замещенные сульфамидные производные
JP2022548690A5 (https=)
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
JP2018524343A5 (https=)
RU2013124101A (ru) Гетероциклические амины и их применения
US12233065B2 (en) Inhibitors of RNA helicase DHX9 and uses thereof
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2013544256A5 (https=)
JP2016523911A5 (https=)
EA028626B1 (ru) БЕНЗИМИДАЗОЛЫ, МОДУЛИРУЮЩИЕ TNF-α
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
HRP20192323T1 (hr) Novi derivati dihidrokinolin-2-ona
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
JP2014532619A5 (https=)
JP2016500073A5 (https=)
IL259424A (en) History of indole converted to nitrogen as pge2 receptor modulators
JPWO2005063743A1 (ja) チアゾール誘導体
JP2014521711A5 (https=)
JP2018530591A5 (https=)
JP2017530185A5 (https=)
HRP20160421T1 (hr) Derivat azola
JP2018520201A5 (https=)
HRP20250272T1 (hr) Derivati benzimidazola i njihova uporaba